Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MitraClip pioneer Ferolyn Powell dies in motorbike accident

This article was originally published in Clinica

Executive Summary

Ferolyn Powell, best known for leading MitraClip developer Evalve, has died in a motorbike accident while on holiday in Thailand. Ms Powell oversaw the development and commercialization of the transcatheter mitral valve repair device, used to minimally-invasively treat mitral valve regurgitation. Evalve, founded in 1999, was acquired by Abbott in in 2009 for $320m upfront and up to $90m in milestones. Ms Powell then joined Abbott as divisional vice-president and general manager of its newly-formed structural heart unit; MitraClip was approved by the US FDA in October 2013. It remains the only minimally-invasive therapy for mitral regurgitation in the US.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts